How biotechs can strengthen their value story with advanced analytics

Small and emerging companies must make big decisions about what to do with their assets early in development. Should they seek venture capital (VC) funding to develop a product themselves or seek a partner once it shows clinical activity? They need to know their product candidate’s value and commercial viability to make the right decision, including the market size, growth and revenue potential.

Recent advances in machine learning and predictive analytics have empowered health economics and outcomes research (HEOR). Sophisticated tools are now available to help build a data-driven value story that can help attract investors and partners, convince payers, and benefit patients. Here are five ways biotech companies can enhance their value story with advanced analytics.


Open PDF

Return to Insights Center

Related Insights

Blog

Using ethical AI to streamline HEOR

Jan 26, 2024

Playbook

Are you using real-world evidence?

Feb 1, 2023

Article

Three strategies for articulating a coherent product value story

Dec 18, 2021

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Whitepaper

Employing Bayesian survival and cost-effectiveness modelling for more informed healthcare decision-making: Practical overview and current perspectives

Mar 28, 2025

Blog

Digital Biomarkers – The Future of Precision Medicine

Jul 21, 2022

Article

How emerging biotechs can enter the Chinese market and prosper

Jan 18, 2022

Podcast

Funding Biotech Innovation: How to Attract Investors

Jan 18, 2022

Blog

Three Ways Early-Stage Companies Can Attract Investors

Feb 3, 2022

Blog

Pragmatic Trials: Targeting evidence generation to inform market access and meet payers’ needs

Feb 8, 2022

Article

Getting to ‘No’ fast is more important when you are small

Mar 4, 2022

Whitepaper

Overview of China's Market Approval Policy Med Insurance Payment System

Apr 7, 2022

Related Insights

Blog

Using ethical AI to streamline HEOR

Jan 26, 2024

Playbook

Are you using real-world evidence?

Feb 1, 2023

Article

Three strategies for articulating a coherent product value story

Dec 18, 2021

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Whitepaper

Employing Bayesian survival and cost-effectiveness modelling for more informed healthcare decision-making: Practical overview and current perspectives

Mar 28, 2025

Blog

Digital Biomarkers – The Future of Precision Medicine

Jul 21, 2022

Show more